Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPT vs DoxyPEP for STI Control in Kenyan MSM
NCT06468462Phase 4Active, not recruiting
- Sponsor
- University of Washington
- Start
- Oct 2025
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefixime, azithromycin, doxycycline in gonorrhea, Chlamydia trachomatis infection (CT), syphilis, sponsored by University of Washington. Started Oct 2025; status: active, not recruiting.
02
Drugs
cefiximeazithromycindoxycycline
03
Conditions
gonorrheaChlamydia trachomatis infection (CT)syphilis
Beyond the preview
Go deeper on NCT06468462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06468462.